VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,568,126 | -98.7% | 58,273 | -98.6% | 0.01% | -99.2% |
| Q4 2022 | $120,112,168 | +13.5% | 4,190,934 | -4.5% | 0.64% | +2.1% |
| Q3 2022 | $105,819,000 | -17.9% | 4,387,189 | -6.8% | 0.63% | -33.7% |
| Q2 2022 | $128,836,000 | -21.9% | 4,705,477 | +9.4% | 0.95% | -32.0% |
| Q1 2022 | $164,905,000 | +598.8% | 4,300,000 | +437.0% | 1.40% | +372.0% |
| Q3 2021 | $23,598,000 | -70.5% | 800,746 | -66.0% | 0.30% | -67.6% |
| Q2 2021 | $80,084,000 | -58.6% | 2,356,805 | -60.4% | 0.91% | -70.2% |
| Q1 2021 | $193,375,000 | -40.7% | 5,950,000 | -34.3% | 3.07% | -33.8% |
| Q4 2020 | $325,981,000 | +131.2% | 9,050,000 | +151.4% | 4.64% | +130.4% |
| Q3 2020 | $140,976,000 | +296.2% | 3,600,000 | +271.1% | 2.01% | +285.4% |
| Q2 2020 | $35,583,000 | -34.3% | 970,100 | -58.7% | 0.52% | -76.5% |
| Q1 2020 | $54,184,000 | – | 2,351,734 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |